China, Oct. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Senaparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma : A Single-Arm, Single-Center Clinical Study'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600134768
Registration Time: 2026/10/20
Type: Interventional study
Primary Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=343108
Published by HT Digital Content Services with permission from Health Daily Digest....